Susquehanna International Group
ARRY

Susquehanna International Group’s Array Biopharma Inc ARRY Stock Holding History

Susquehanna International Group’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,072,700
Closed -$49.7M – 11270
2019
Q2 		$49.7M Buy
1,072,700
+859,200
+402% +$24.1M 0.02% 690
2019
Q1 		$5.21M Buy
213,500
+51,200
+32% +$1.07M ﹤0.01% 2403
2018
Q4 		$2.31M Sell
162,300
-11,700
-7% -$177K ﹤0.01% 3312
2018
Q3 		$2.65M Sell
174,000
-241,000
-58% -$3.69M ﹤0.01% 3558
2018
Q2 		$6.96M Buy
415,000
+263,300
+174% +$4.19M ﹤0.01% 2344
2018
Q1 		$2.48M Sell
151,700
-129,400
-46% -$2.07M ﹤0.01% 3542
2017
Q4 		$3.6M Sell
281,100
-300,100
-52% -$3.41M ﹤0.01% 2951
2017
Q3 		$7.15M Sell
581,200
-227,600
-28% -$2.11M ﹤0.01% 2101
2017
Q2 		$6.77M Sell
808,800
-208,300
-20% -$1.7M ﹤0.01% 2056
2017
Q1 		$9.09M Buy
1,017,100
+731,800
+257% +$7.79M ﹤0.01% 1713
2016
Q4 		$2.51M Buy
285,300
+73,400
+35% +$540K ﹤0.01% 3590
2016
Q3 		$1.43M Buy
211,900
+106,600
+101% +$412K ﹤0.01% 4142
2016
Q2 		$375K Sell
105,300
-65,400
-38% -$213K ﹤0.01% 6608
2016
Q1 		$504K Sell
170,700
-271,700
-61% -$814K ﹤0.01% 6387
2015
Q4 		$1.87M Sell
442,400
-423,500
-49% -$1.93M ﹤0.01% 4169
2015
Q3 		$3.95M Buy
865,900
+472,900
+120% +$2.8M ﹤0.01% 3026
2015
Q2 		$2.83M Sell
393,000
-566,100
-59% -$4.18M ﹤0.01% 3964
2015
Q1 		$7.07M Buy
959,100
+316,200
+49% +$2.25M ﹤0.01% 2266
2014
Q4 		$3.04M Buy
642,900
+533,900
+490% +$2.11M ﹤0.01% 3724
2014
Q3 		$389K Buy
109,000
+21,500
+25% +$84.8K ﹤0.01% 7637
2014
Q2 		$399K Sell
87,500
-256,100
-75% -$1.06M ﹤0.01% 7891
2014
Q1 		$1.61M Sell
343,600
-77,600
-18% -$390K ﹤0.01% 4684
2013
Q4 		$2.11M Buy
421,200
+338,800
+411% +$1.84M ﹤0.01% 4179
2013
Q3 		$513K Buy
82,400
+23,100
+39% +$137K ﹤0.01% 6381
2013
Q2 		$269K Buy
+59,300
New +$319K ﹤0.01% 6985

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Susquehanna International Group's ARRY Position: Q3 2019 in Review

Susquehanna International Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 581,140 shares — an estimated $26.9M sold.

Susquehanna International Group first reported a position in ARRY in Q2 2013 and held it in 20 quarters. The position peaked at $26.9M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Susquehanna International Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Susquehanna International Group sold 581,140 Array Biopharma Inc shares in Q3 2019, an estimated $26.9M.
  • Susquehanna International Group first reported a position in Array Biopharma Inc in Q2 2013 and held it in 20 quarters.
  • Susquehanna International Group's Array Biopharma Inc position peaked at $26.9M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.